| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prolactin receptor binding | 1.37e-09 | 7 | 186 | 5 | GO:0005148 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 1.61e-08 | 10 | 186 | 5 | GO:0005131 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 1.49e-05 | 34 | 186 | 5 | GO:0051427 | |
| GeneOntologyMolecularFunction | BRE binding | 8.63e-05 | 2 | 186 | 2 | GO:0042835 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.06e-04 | 229 | 186 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 4.91e-04 | 17 | 186 | 3 | GO:0000900 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone biosynthetic process | 1.14e-08 | 19 | 184 | 6 | GO:0046886 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 6.50e-08 | 13 | 184 | 5 | GO:0090031 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone metabolic process | 9.22e-08 | 26 | 184 | 6 | GO:0032352 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 7.24e-07 | 36 | 184 | 6 | GO:0046885 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid metabolic process | 1.87e-06 | 42 | 184 | 6 | GO:0045940 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 1.98e-06 | 24 | 184 | 5 | GO:0090030 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | HLA-E GH1 GH2 ALMS1 CELF1 CSH1 BRCA2 CSH2 CSHL1 VPS13A FKBP8 KDM6A | 2.56e-06 | 249 | 184 | 12 | GO:0035264 |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 3.02e-06 | 26 | 184 | 5 | GO:0060396 | |
| GeneOntologyBiologicalProcess | positive regulation of multicellular organism growth | 3.68e-06 | 47 | 184 | 6 | GO:0040018 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 3.68e-06 | 27 | 184 | 5 | GO:0071378 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via JAK-STAT | 1.28e-05 | 58 | 184 | 6 | GO:0046427 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.28e-05 | 58 | 184 | 6 | GO:0032350 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.28e-05 | 87 | 184 | 7 | GO:0033143 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 1.99e-05 | 93 | 184 | 7 | GO:0040014 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid biosynthetic process | 2.12e-05 | 38 | 184 | 5 | GO:0010893 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via STAT | 2.48e-05 | 65 | 184 | 6 | GO:1904894 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 3.09e-05 | 41 | 184 | 5 | GO:0060416 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 5.45e-05 | 46 | 184 | 5 | GO:0032107 | |
| GeneOntologyBiologicalProcess | developmental growth | CARM1 ISLR2 HLA-E TTC3 GH1 GH2 PTPN12 CYFIP1 SEMA6D ALMS1 CELF1 CSH1 BRCA2 CSH2 CSHL1 TLL2 VPS13A ASPM NINJ1 FKBP8 KDM6A | 6.66e-05 | 911 | 184 | 21 | GO:0048589 |
| GeneOntologyBiologicalProcess | mitotic DNA replication maintenance of fidelity | 7.92e-05 | 2 | 184 | 2 | GO:1990505 | |
| GeneOntologyBiologicalProcess | mitotic recombination-dependent replication fork processing | 7.92e-05 | 2 | 184 | 2 | GO:1990426 | |
| GeneOntologyBiologicalProcess | cell cycle DNA replication maintenance of fidelity | 7.92e-05 | 2 | 184 | 2 | GO:1902298 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | CARM1 ISLR2 FLT1 PIEZO1 VSTM2A LAMC1 PLXND1 ZNF385A PIAS1 TRAK1 GH1 GH2 ARNT CYFIP1 ALX1 CSH1 CSH2 CSHL1 HEY1 ASPM SCUBE3 NINJ1 NOCT SETD3 | 8.25e-05 | 1141 | 184 | 24 | GO:0045597 |
| GeneOntologyBiologicalProcess | hormone biosynthetic process | 9.92e-05 | 83 | 184 | 6 | GO:0042446 | |
| GeneOntologyBiologicalProcess | response to food | 1.67e-04 | 58 | 184 | 5 | GO:0032094 | |
| GeneOntologyBiologicalProcess | nuclear division | RAD51 CDC14C UBR2 ERCC4 INO80 SMC2 SGO1 USP16 CDC14B BROX BRCA2 MEIOC ASPM HFM1 | 2.12e-04 | 512 | 184 | 14 | GO:0000280 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.22e-04 | 136 | 184 | 7 | GO:0030518 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | ISLR2 FLT1 PLXND1 TTC3 TRAK1 GH1 GH2 CYFIP1 SEMA6D CSH1 CSH2 CSHL1 HEY1 ASPM | 2.25e-04 | 515 | 184 | 14 | GO:0050767 |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose transmembrane transport | 2.47e-04 | 63 | 184 | 5 | GO:0010828 | |
| GeneOntologyBiologicalProcess | telomere maintenance via recombination | 2.94e-04 | 15 | 184 | 3 | GO:0000722 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 3.15e-04 | 240 | 184 | 9 | GO:0140013 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 3.42e-04 | 104 | 184 | 6 | GO:0007405 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 3.52e-04 | 354 | 184 | 11 | GO:0050769 | |
| GeneOntologyBiologicalProcess | oligosaccharide catabolic process | 3.59e-04 | 16 | 184 | 3 | GO:0009313 | |
| GeneOntologyBiologicalProcess | positive regulation of tyrosine phosphorylation of STAT protein | 3.79e-04 | 69 | 184 | 5 | GO:0042531 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | ISLR2 TTC3 GH1 GH2 CYFIP1 SEMA6D ALMS1 CELF1 CSH1 CSH2 CSHL1 TLL2 | 4.16e-04 | 421 | 184 | 12 | GO:0048638 |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 4.69e-04 | 4 | 184 | 2 | GO:0046352 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 4.69e-04 | 4 | 184 | 2 | GO:0140973 | |
| GeneOntologyBiologicalProcess | neuron projection development | CARM1 ISLR2 DPYSL2 DPYSL3 MYO6 HLA-E DOCK10 LAMC1 ITGA1 PLXND1 TTC3 CSMD3 TRAK1 CYFIP1 TRIM67 SEMA6D ALMS1 HEY1 CLMN AVIL CNTN5 VPS13A TMEM30A ATP2B2 | 4.82e-04 | 1285 | 184 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 4.92e-04 | 155 | 184 | 7 | GO:0043401 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 5.57e-04 | 75 | 184 | 5 | GO:0048286 | |
| GeneOntologyBiologicalProcess | organelle fission | RAD51 CDC14C UBR2 ERCC4 INO80 SMC2 SGO1 USP16 CDC14B BROX BRCA2 MEIOC ASPM HFM1 | 6.30e-04 | 571 | 184 | 14 | GO:0048285 |
| GeneOntologyBiologicalProcess | response to light stimulus | 6.63e-04 | 382 | 184 | 11 | GO:0009416 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 7.00e-04 | 268 | 184 | 9 | GO:1903046 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid metabolic process | 7.13e-04 | 165 | 184 | 7 | GO:0045834 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 3.32e-10 | 6 | 188 | 5 | GO:0070195 | |
| GeneOntologyCellularComponent | secretory granule | RAB9B MGAM ATP8B4 MANBA IMPDH2 CEL FOLR3 CD300A GPR84 ACTN1 ITGA1 GH1 GH2 CYFIP1 CSH1 BRCA2 CSH2 CSHL1 VPS13A TMEM30A LTA4H PLD1 FRMPD3 DYNC1H1 PROS1 | 4.69e-06 | 1014 | 188 | 25 | GO:0030141 |
| GeneOntologyCellularComponent | secretory vesicle | RAB9B MGAM DPYSL3 ATP8B4 MANBA IMPDH2 CEL FOLR3 CD300A GPR84 ACTN1 ITGA1 GH1 GH2 CYFIP1 CSH1 BRCA2 CSH2 CSHL1 TRIM9 VPS13A TMEM30A LTA4H SLC2A13 PLD1 FRMPD3 DYNC1H1 PROS1 | 6.94e-06 | 1246 | 188 | 28 | GO:0099503 |
| GeneOntologyCellularComponent | tertiary granule | 1.82e-05 | 164 | 188 | 9 | GO:0070820 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 5.04e-05 | 73 | 188 | 6 | GO:0070821 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 2.42e-04 | 14 | 188 | 3 | GO:1990531 | |
| MousePheno | decreased pituitary gland weight | 8.29e-09 | 8 | 154 | 5 | MP:0008938 | |
| MousePheno | absent somatotrophs | 1.85e-08 | 9 | 154 | 5 | MP:0008330 | |
| MousePheno | absent lactotrophs | 1.85e-08 | 9 | 154 | 5 | MP:0008333 | |
| MousePheno | increased circulating ghrelin level | 1.13e-07 | 12 | 154 | 5 | MP:0011612 | |
| MousePheno | abnormal pituitary gland weight | 1.13e-07 | 12 | 154 | 5 | MP:0008937 | |
| MousePheno | abnormal circulating ghrelin level | 4.18e-07 | 15 | 154 | 5 | MP:0011611 | |
| MousePheno | decreased lactotroph cell number | 8.46e-07 | 17 | 154 | 5 | MP:0008332 | |
| MousePheno | abnormal lactotroph morphology | 1.56e-06 | 19 | 154 | 5 | MP:0008323 | |
| MousePheno | decreased somatotroph cell number | 2.68e-06 | 21 | 154 | 5 | MP:0008329 | |
| MousePheno | small adenohypophysis | 4.36e-06 | 23 | 154 | 5 | MP:0008321 | |
| MousePheno | abnormal somatotroph morphology | 5.46e-06 | 24 | 154 | 5 | MP:0008322 | |
| MousePheno | delayed vaginal opening | 1.22e-05 | 28 | 154 | 5 | MP:0002636 | |
| MousePheno | small pituitary gland | 1.73e-05 | 30 | 154 | 5 | MP:0005361 | |
| MousePheno | abnormal timing of vaginal opening | 2.05e-05 | 31 | 154 | 5 | MP:0020150 | |
| MousePheno | increased white adipose tissue amount | 2.17e-05 | 52 | 154 | 6 | MP:0000008 | |
| MousePheno | decreased spleen weight | 3.48e-05 | 113 | 154 | 8 | MP:0004953 | |
| MousePheno | abnormal pituitary gland size | 9.31e-05 | 42 | 154 | 5 | MP:0008936 | |
| MousePheno | increased brown adipose tissue amount | 1.04e-04 | 43 | 154 | 5 | MP:0000005 | |
| MousePheno | delayed sexual maturation | 1.96e-04 | 49 | 154 | 5 | MP:0001938 | |
| MousePheno | abnormal forebrain morphology | CARM1 ISLR2 MANBA ARFGEF2 LAMC1 CSMD3 PRDM2 GH1 GH2 CACNG2 ARNT ALX1 TRIM67 CSH1 CSH2 CSHL1 TRIM9 PCDH19 VPS13A ASPM FKBP8 ATP2B2 KDM6A DYNC1H1 PROS1 | 2.72e-04 | 1072 | 154 | 25 | MP:0000783 |
| MousePheno | abnormal vitelline vasculature morphology | 2.76e-04 | 235 | 154 | 10 | MP:0003229 | |
| MousePheno | disproportionate dwarf | 4.01e-04 | 57 | 154 | 5 | MP:0002427 | |
| Domain | SOMATOTROPIN_2 | 5.68e-10 | 6 | 187 | 5 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 5.68e-10 | 6 | 187 | 5 | PS00266 | |
| Domain | Hormone_1 | 5.68e-10 | 6 | 187 | 5 | PF00103 | |
| Domain | Somatotropin | 1.97e-09 | 7 | 187 | 5 | IPR001400 | |
| Domain | Somatotropin_CS | 4.83e-08 | 5 | 187 | 4 | IPR018116 | |
| Domain | CUB | 9.09e-06 | 49 | 187 | 6 | PF00431 | |
| Domain | CUB | 1.02e-05 | 50 | 187 | 6 | SM00042 | |
| Domain | - | 1.29e-05 | 52 | 187 | 6 | 2.60.120.290 | |
| Domain | CUB | 1.44e-05 | 53 | 187 | 6 | PS01180 | |
| Domain | CUB_dom | 2.21e-05 | 57 | 187 | 6 | IPR000859 | |
| Domain | 4_helix_cytokine-like_core | 9.79e-05 | 74 | 187 | 6 | IPR009079 | |
| Domain | TPR-contain_dom | 1.36e-04 | 150 | 187 | 8 | IPR013026 | |
| Domain | 4_helix_cytokine_core | 1.54e-04 | 51 | 187 | 5 | IPR012351 | |
| Domain | TPR_REGION | 2.62e-04 | 165 | 187 | 8 | PS50293 | |
| Domain | TPR | 2.62e-04 | 165 | 187 | 8 | PS50005 | |
| Domain | TPR_1 | 2.88e-04 | 90 | 187 | 6 | IPR001440 | |
| Domain | TPR_1 | 2.88e-04 | 90 | 187 | 6 | PF00515 | |
| Domain | ALMS_motif | 2.97e-04 | 3 | 187 | 2 | IPR029299 | |
| Domain | ALMS_motif | 2.97e-04 | 3 | 187 | 2 | PF15309 | |
| Domain | Glyco_hydro_31_CS | 5.90e-04 | 4 | 187 | 2 | IPR030459 | |
| Domain | Gal_mutarotase_N | 5.90e-04 | 4 | 187 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 5.90e-04 | 4 | 187 | 2 | PF16863 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 9.39e-08 | 13 | 136 | 5 | MM14516 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.11e-07 | 16 | 136 | 5 | MM15710 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 8.10e-07 | 19 | 136 | 5 | MM1513 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 1.07e-06 | 20 | 136 | 5 | MM15070 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 4.34e-06 | 26 | 136 | 5 | MM1345 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 7.65e-06 | 29 | 136 | 5 | MM1522 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.48e-05 | 33 | 136 | 5 | MM1404 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | RAB9B MGAM ATP8B4 MANBA IMPDH2 FOLR3 CD300A GPR84 CYFIP1 TMEM30A LTA4H PLD1 FRMPD3 DYNC1H1 | 2.12e-04 | 478 | 136 | 14 | M27620 |
| Pathway | WP_ADIPOGENESIS_GENES | 3.62e-04 | 137 | 136 | 7 | MM15970 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 3.67e-04 | 15 | 136 | 3 | M552 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 3.75e-04 | 64 | 136 | 5 | M7923 | |
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 4.49e-12 | 5 | 189 | 5 | 31479305 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 10767558 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 18006625 | ||
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 4.49e-12 | 5 | 189 | 5 | 24218587 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 4.49e-12 | 5 | 189 | 5 | 16201410 | |
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 4.49e-12 | 5 | 189 | 5 | 11487592 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 11318985 | ||
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 4.49e-12 | 5 | 189 | 5 | 17272398 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 20707609 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 1874564 | ||
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 4.49e-12 | 5 | 189 | 5 | 32100023 | |
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 4.49e-12 | 5 | 189 | 5 | 10810296 | |
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 4.49e-12 | 5 | 189 | 5 | 7965203 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 17347312 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 21852148 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 12175649 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 15070902 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 4.49e-12 | 5 | 189 | 5 | 24758742 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 4.49e-12 | 5 | 189 | 5 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 4.49e-12 | 5 | 189 | 5 | 23639351 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 21098290 | ||
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 4.49e-12 | 5 | 189 | 5 | 18948397 | |
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 4.49e-12 | 5 | 189 | 5 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 4.49e-12 | 5 | 189 | 5 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 4.49e-12 | 5 | 189 | 5 | 16508206 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 15616010 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 4.49e-12 | 5 | 189 | 5 | 32556100 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 4.49e-12 | 5 | 189 | 5 | 11346667 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 12010633 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 4.49e-12 | 5 | 189 | 5 | 17626886 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 19359380 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 15316240 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 4.49e-12 | 5 | 189 | 5 | 18203262 | |
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 4.49e-12 | 5 | 189 | 5 | 2249485 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 17242167 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 18180319 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 4.49e-12 | 5 | 189 | 5 | 12225773 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 3780533 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 10395045 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 4.49e-12 | 5 | 189 | 5 | 8552145 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 4.49e-12 | 5 | 189 | 5 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 4.49e-12 | 5 | 189 | 5 | 8647448 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 26887678 | ||
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 4.49e-12 | 5 | 189 | 5 | 8756530 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 31099824 | ||
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 4.49e-12 | 5 | 189 | 5 | 1980158 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 4.49e-12 | 5 | 189 | 5 | 23861378 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 4.49e-12 | 5 | 189 | 5 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 4.49e-12 | 5 | 189 | 5 | 11350075 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 18617616 | ||
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 4.49e-12 | 5 | 189 | 5 | 10974531 | |
| Pubmed | 4.49e-12 | 5 | 189 | 5 | 23428905 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 4.49e-12 | 5 | 189 | 5 | 17761891 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 12399427 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 2.68e-11 | 6 | 189 | 5 | 20032199 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 11316754 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 23150490 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 2991252 | ||
| Pubmed | Third party data gene data set of eutherian growth hormone genes. | 2.68e-11 | 6 | 189 | 5 | 26697363 | |
| Pubmed | Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. | 2.68e-11 | 6 | 189 | 5 | 15985453 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 20863500 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 12208853 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 9175714 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 16141391 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 18618017 | ||
| Pubmed | Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. | 2.68e-11 | 6 | 189 | 5 | 14759511 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 15166120 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 24691732 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 38951485 | ||
| Pubmed | Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. | 2.68e-11 | 6 | 189 | 5 | 14530511 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 21849508 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 33368660 | ||
| Pubmed | Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. | 2.68e-11 | 6 | 189 | 5 | 14702113 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 9556071 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 8990189 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 12933669 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 22890843 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 15138153 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 30333823 | ||
| Pubmed | GH/STAT5 signaling during the growth period in livers of mice overexpressing GH. | 2.68e-11 | 6 | 189 | 5 | 25691498 | |
| Pubmed | The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. | 2.68e-11 | 6 | 189 | 5 | 23349524 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 26762506 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 25811804 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 19619004 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 14563698 | ||
| Pubmed | The human growth hormone locus: nucleotide sequence, biology, and evolution. | 2.68e-11 | 6 | 189 | 5 | 2744760 | |
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 14596666 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 11309401 | ||
| Pubmed | 2.68e-11 | 6 | 189 | 5 | 25017732 | ||
| Interaction | CSH2 interactions | 1.77e-07 | 15 | 186 | 5 | int:CSH2 | |
| Interaction | CSH1 interactions | 4.93e-07 | 18 | 186 | 5 | int:CSH1 | |
| Interaction | GH1 interactions | 1.17e-05 | 16 | 186 | 4 | int:GH1 | |
| Cytoband | 17q24.2 | 2.46e-09 | 30 | 189 | 6 | 17q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 1.11e-05 | 120 | 189 | 6 | chr17q23 | |
| Cytoband | 1p22.2 | 2.09e-04 | 28 | 189 | 3 | 1p22.2 | |
| Cytoband | Xq22.1-q22.3 | 2.50e-04 | 6 | 189 | 2 | Xq22.1-q22.3 | |
| GeneFamily | Growth hormone family | 9.43e-11 | 6 | 127 | 5 | 1175 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.61e-04 | 115 | 127 | 6 | 769 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.54e-04 | 20 | 127 | 3 | 548 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CPEB2 RAB9B DPYSL3 CELF4 ZBTB38 VSTM2A NOX4 TTC3 CSMD3 PRDM2 CACNG2 FSIP2 ZNF385D TRIM67 SEMA6D CELF1 CELF2 NALCN CSRNP3 TRIM9 ASXL3 CNTN5 PCDH19 FRMPD3 CSMD1 ATP2B2 IGSF3 | 2.71e-08 | 1106 | 188 | 27 | M39071 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CPEB2 TPP2 KLHL2 DPYSL3 CDV3 ERCC4 DEAF1 MYO6 ASIC1 SPTBN1 NASP CUBN FOCAD SEMA6D PER3 ALMS1 HEY1 CLMN PCDH19 TMEM30A CEP295 SLC2A13 FKBP8 KDM6A PIGO PROS1 | 9.87e-08 | 1102 | 188 | 26 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CPEB2 TPP2 KLHL2 DPYSL3 CDV3 ERCC4 DEAF1 MYO6 ASIC1 SPTBN1 NASP CUBN FOCAD SEMA6D PER3 ALMS1 HEY1 CLMN PCDH19 TMEM30A CEP295 SLC2A13 FKBP8 KDM6A PIGO PROS1 | 1.45e-07 | 1124 | 188 | 26 | MM1070 |
| Coexpression | ZAMORA_NOS2_TARGETS_UP | 4.56e-06 | 60 | 188 | 6 | MM1165 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 6.75e-06 | 181 | 188 | 9 | M2969 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 6.85e-06 | 137 | 188 | 8 | M39241 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CPEB2 DPYSL2 FLT1 ZBTB38 MYO6 HLA-E PSD3 ARNT PTPN12 CELF2 ART3 VPS13A TMEM30A SPOP C1QTNF7 PLD1 NOCT KDM6A PROS1 | 1.35e-05 | 854 | 188 | 19 | M1533 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CPEB2 DPYSL3 CELF4 ZBTB38 VSTM2A ZNF362 CSMD3 CACNG2 TRIM67 SEMA6D CELF2 NALCN CSRNP3 ASXL3 PCDH19 CSMD1 ATP2B2 | 1.37e-05 | 703 | 188 | 17 | M39070 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP | 1.45e-05 | 199 | 188 | 9 | M7712 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 1.50e-05 | 200 | 188 | 9 | M5089 | |
| Coexpression | WANG_LSD1_TARGETS_DN | 1.74e-05 | 45 | 188 | 5 | MM740 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | KLHL2 ATP8B4 ASIC1 KIAA0232 ARFGEF2 GBP3 CDC14B ST14 ELMO1 PPL TRAK1 FCGBP HEY1 CLMN SLC2A13 PLD1 GOLGB1 | 2.06e-05 | 726 | 188 | 17 | M4210 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | RAB9B DPYSL3 CELF4 DEAF1 VSTM2A CACNG2 TRIM67 SEMA6D NALCN CSRNP3 ASXL3 CNTN5 FRMPD3 CSMD1 | 2.19e-05 | 513 | 188 | 14 | M39069 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CPEB2 DPYSL2 FLT1 ZBTB38 MYO6 HLA-E PSD3 ARNT PTPN12 CELF2 ART3 VPS13A TMEM30A SPOP C1QTNF7 PLD1 NOCT KDM6A PROS1 | 2.31e-05 | 888 | 188 | 19 | MM1018 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAM21 CST9 PLXND1 FREM3 SERPINH1 ST14 GH1 GH2 SEMA6D CSH1 CSH2 CSHL1 TLL2 SCUBE3 SERPINC1 C1QTNF7 ANGPTL7 | 2.54e-05 | 738 | 188 | 17 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAM21 CST9 PLXND1 FREM3 SERPINH1 ST14 GH1 GH2 SEMA6D CSH1 CSH2 CSHL1 TLL2 SCUBE3 SERPINC1 C1QTNF7 ANGPTL7 | 3.16e-05 | 751 | 188 | 17 | M5885 |
| Coexpression | NABA_MATRISOME | AMELY ADAM21 CST9 LAMC1 CHAD PLXND1 FREM3 SERPINH1 ST14 GH1 GH2 SEMA6D CSH1 CSH2 CSHL1 TLL2 SCUBE3 SERPINC1 C1QTNF7 ANGPTL7 | 4.06e-05 | 1008 | 188 | 20 | MM17056 |
| Coexpression | NABA_MATRISOME | AMELY ADAM21 CST9 LAMC1 CHAD PLXND1 FREM3 SERPINH1 ST14 GH1 GH2 SEMA6D CSH1 CSH2 CSHL1 TLL2 SCUBE3 SERPINC1 C1QTNF7 ANGPTL7 | 5.18e-05 | 1026 | 188 | 20 | M5889 |
| Coexpression | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN | 5.57e-05 | 57 | 188 | 5 | MM807 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN | 6.69e-05 | 188 | 188 | 8 | M8252 | |
| Coexpression | E2F1_UP.V1_UP | 6.69e-05 | 188 | 188 | 8 | M2632 | |
| Coexpression | GSE27786_BCELL_VS_CD4_TCELL_DN | 9.61e-05 | 198 | 188 | 8 | M4800 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP | DPYSL3 ASIC1 DDX42 GPR84 NOX4 ANKRD50 BROX TLL2 NINJ1 C1QTNF7 PLD1 ATP2B2 IGSF3 | 9.87e-05 | 517 | 188 | 13 | M7140 |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 9.95e-05 | 199 | 188 | 8 | M3070 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN | 1.03e-04 | 200 | 188 | 8 | M9935 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN | 1.03e-04 | 200 | 188 | 8 | M5048 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 1.03e-04 | 200 | 188 | 8 | M7776 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN | 1.03e-04 | 200 | 188 | 8 | M4314 | |
| Coexpression | BIDUS_METASTASIS_DN | 1.28e-04 | 154 | 188 | 7 | M8818 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | KLHL2 DPYSL2 CDV3 CELF4 ZBTB38 PSD3 DOCK10 ARFGEF2 TTC3 ELMO1 PPL SEMA6D PER3 TRIM9 SLC2A13 SETD3 DYNC1H1 GOLGB1 | 1.68e-04 | 946 | 188 | 18 | M39169 |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 1.94e-04 | 116 | 188 | 6 | M2379 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 1.94e-04 | 74 | 188 | 5 | MM769 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 2.03e-04 | 117 | 188 | 6 | MM931 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.04e-04 | 221 | 188 | 8 | M39222 | |
| Coexpression | GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN | 2.35e-04 | 170 | 188 | 7 | M2942 | |
| Coexpression | GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN | 2.35e-04 | 170 | 188 | 7 | M6852 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | MGAM DPYSL3 SPTBN1 VSTM2A NASP NOX4 SMC2 NALCN TRIM9 CLMN ASXL3 PCDH19 ASPM CEP295 C1QTNF7 CPLANE1 | 6.26e-07 | 413 | 183 | 16 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.91e-07 | 115 | 183 | 9 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 1.96e-06 | 68 | 183 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | MGAM DPYSL3 SPTBN1 VSTM2A DDX42 NASP NOX4 KDM5D SMC2 ALX1 NALCN CSRNP3 TRIM9 CLMN ASXL3 PCDH19 ASPM CEP295 C1QTNF7 CPLANE1 KDM6A | 6.01e-06 | 801 | 183 | 21 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000 | CPEB2 ATP8B4 SETDB2 PTPN12 ALMS1 BRCA2 MEIOC SACS ATF7IP2 VPS13A | 1.48e-05 | 210 | 183 | 10 | gudmap_developingGonad_e14.5_ ovary_1000_k1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.64e-05 | 129 | 183 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | TPP2 DPYSL2 ARFGEF2 NASP LAMC1 PHYHD1 INO80 SMC2 ELMO1 CELF1 VPS13A ASPM CPLANE1 | 2.01e-05 | 369 | 183 | 13 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.67e-05 | 187 | 183 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | CPEB2 ATP8B4 SPTBN1 NASP SMC2 SETDB2 PTPN12 PER3 ALMS1 BRCA2 MEIOC SACS KLHL15 ATF7IP2 VPS13A CEP295 CPLANE1 DNAH8 KDM6A | 4.35e-05 | 776 | 183 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | MGAM DPYSL3 SPTBN1 VSTM2A NASP SMC2 NALCN ASXL3 ASPM CEP295 C1QTNF7 CPLANE1 KDM6A | 5.38e-05 | 406 | 183 | 13 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPP2 POP4 NASP SMC2 SGO1 TTC3 USP16 PIAS1 ZNF490 PTPN12 KCNT2 ALMS1 BRCA2 TJP1 ASPM | 6.11e-05 | 532 | 183 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 7.98e-05 | 161 | 183 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.80e-04 | 136 | 183 | 7 | gudmap_kidney_adult_RenalCapsule_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 1.81e-04 | 61 | 183 | 5 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.18e-04 | 99 | 183 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPP2 DPYSL2 DPYSL3 VSTM2A ARFGEF2 NASP LAMC1 PHYHD1 INO80 SMC2 ELMO1 CELF1 CSRNP3 PCDH19 VPS13A ASPM CPLANE1 IGSF3 | 2.19e-04 | 806 | 183 | 18 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | placenta | FLT1 LAMC1 TRIM64 GH1 GH2 TRIM64B SEMA6D CSH1 CSH2 CSHL1 CNTN5 | 2.33e-04 | 349 | 183 | 11 | placenta |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 2.46e-04 | 143 | 183 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | CELF4 VSTM2A PSD3 NASP PHYHD1 GALNT16 TFDP2 TRAK1 FBXO25 ALMS1 CELF2 CSRNP3 TRIM9 TJP1 PCDH19 ASPM PLD1 ATP2B2 PIGO | 2.69e-04 | 893 | 183 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | RAD51 CPEB2 ARFGEF2 ZNF622 CUBN SETDB2 FBXO25 ALMS1 BRCA2 MEIOC ATF7IP2 VPS13A HFM1 CEP295 SETD3 CPLANE1 CCDC171 DNAH8 | 2.70e-04 | 820 | 183 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | RAD51 CPEB2 ARFGEF2 CUBN ELMO1 SETDB2 NAA25 ALMS1 BRCA2 CSRNP3 MEIOC ATF7IP2 VPS13A HFM1 SETD3 CPLANE1 DNAH8 KPNA2 | 2.78e-04 | 822 | 183 | 18 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | KLHL2 MGAM DPYSL3 NASP SMC2 ALX1 CSRNP3 TRIM9 ASXL3 ASPM CEP295 KDM6A | 2.80e-04 | 417 | 183 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 3.03e-04 | 148 | 183 | 7 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | LDLRAP1 DPYSL3 CELF4 NASP PHYHD1 GALNT16 TFDP2 TRAK1 LPIN3 FBXO25 ALMS1 CELF2 BRCA2 PCDH19 VPS13A ASPM C1QTNF7 PLD1 CCDC171 ATP2B2 | 3.30e-04 | 983 | 183 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.42e-04 | 151 | 183 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | CPEB2 PSD3 DOCK10 ZNF362 ACTN1 KDM5D CDC14B TFDP2 ALX1 HEY1 CLMN ASXL3 CNTN5 RASEF C1QTNF7 PLD1 CCDC171 DSE | 4.08e-04 | 849 | 183 | 18 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 4.17e-04 | 156 | 183 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | RAD51 SKIDA1 LAMC1 SGO1 ALMS1 HEY1 PCDH19 EDDM3B ASPM SCUBE3 | 4.33e-04 | 316 | 183 | 10 | gudmap_kidney_P3_CapMes_Crym_k4_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | KLHL2 MGAM DPYSL3 SPTBN1 VSTM2A DDX42 NASP NOX4 SMC2 NALCN CLMN ASXL3 ASPM CEP295 C1QTNF7 CPLANE1 KDM6A | 5.02e-04 | 790 | 183 | 17 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | BM Top 100 - pituitary gland | 5.07e-04 | 76 | 183 | 5 | BM Top 100 - pituitary gland | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | RAD51 ARFGEF2 SETDB2 ALMS1 BRCA2 MEIOC ATF7IP2 VPS13A HFM1 CPLANE1 DNAH8 | 5.33e-04 | 385 | 183 | 11 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DPYSL3 ATP8B4 SPTBN1 NASP SMC2 FOCAD SEMA6D MEIOC SACS KLHL15 ATF7IP2 ASPM CEP295 C1QTNF7 CPLANE1 DNAH8 KDM6A | 5.39e-04 | 795 | 183 | 17 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_200 | 6.04e-04 | 45 | 183 | 4 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_200 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DLGAP2 ACTN1 CSMD3 FOCAD CELF2 CSRNP3 TRIM9 VPS13A CSMD1 ATP2B2 | 1.19e-08 | 195 | 189 | 10 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DLGAP2 CELF4 TTC3 CSMD3 FOCAD CELF2 CSRNP3 SLC2A13 CSMD1 ATP2B2 | 1.38e-08 | 198 | 189 | 10 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.53e-07 | 194 | 189 | 9 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-07 | 198 | 189 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-07 | 198 | 189 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-07 | 198 | 189 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-07 | 198 | 189 | 9 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.99e-07 | 200 | 189 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-06 | 182 | 189 | 8 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 185 | 189 | 8 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 187 | 189 | 8 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.46e-06 | 188 | 189 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 188 | 189 | 8 | 1efbc99bcd6542e5d9fa91edb7c4295167914786 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.52e-06 | 189 | 189 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 192 | 189 | 8 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.78e-06 | 193 | 189 | 8 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 195 | 189 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 195 | 189 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-06 | 196 | 189 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 189 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-06 | 196 | 189 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Non-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster | 2.15e-06 | 198 | 189 | 8 | dd38840a96171f58da243daa22b013e15a81db4a | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster | 2.15e-06 | 198 | 189 | 8 | 9fc1035ea447a4551a66944c869c4671e17cec61 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-06 | 198 | 189 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster | 2.15e-06 | 198 | 189 | 8 | 21efb7bcd24f24d20791b34e75d6f9d46a129481 | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 2.23e-06 | 199 | 189 | 8 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 2.23e-06 | 199 | 189 | 8 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 200 | 189 | 8 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 200 | 189 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 200 | 189 | 8 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 200 | 189 | 8 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 200 | 189 | 8 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-06 | 200 | 189 | 8 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.32e-06 | 200 | 189 | 8 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.32e-06 | 200 | 189 | 8 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Interneuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-06 | 200 | 189 | 8 | 08bee924a2654e05df3b39e8a51f93c8b3472175 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.66e-06 | 150 | 189 | 7 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.55e-06 | 155 | 189 | 7 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.84e-06 | 161 | 189 | 7 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.86e-06 | 165 | 189 | 7 | 6a621b300442c52adfc15b61d3a6d3a3cb00099f | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.42e-06 | 167 | 189 | 7 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.70e-06 | 174 | 189 | 7 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.17e-05 | 179 | 189 | 7 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-05 | 181 | 189 | 7 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-05 | 181 | 189 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.30e-05 | 182 | 189 | 7 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 182 | 189 | 7 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.30e-05 | 182 | 189 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.30e-05 | 182 | 189 | 7 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative|Bac-SEP / Disease, Lineage and Cell Type | 1.39e-05 | 184 | 189 | 7 | 848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.44e-05 | 185 | 189 | 7 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 186 | 189 | 7 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 186 | 189 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Control-Myeloid-MoAM5|Control / Disease group,lineage and cell class （2021.01.30） | 1.55e-05 | 187 | 189 | 7 | 8769341be67382cea2a590d962f4def7c39de883 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.55e-05 | 187 | 189 | 7 | 0d589de12108230ced5b60229564f4a181e2f172 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-05 | 187 | 189 | 7 | 59d28f4ee1d463ae20abb8d7e7399b504d80698a | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.55e-05 | 187 | 189 | 7 | 25adf648c05c21534b4913254e73d43fc5f64e06 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM5|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.55e-05 | 187 | 189 | 7 | 3b0cfa9e5ea5e7d6dda689c328b9b5110b43ee1d | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.55e-05 | 187 | 189 | 7 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 188 | 189 | 7 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 188 | 189 | 7 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-05 | 188 | 189 | 7 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Interneuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.65e-05 | 126 | 189 | 6 | ec445ec097c9c45cd47b8cfa8c140df5b298695e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-05 | 190 | 189 | 7 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.77e-05 | 191 | 189 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.83e-05 | 192 | 189 | 7 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 192 | 189 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 1.90e-05 | 193 | 189 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-05 | 194 | 189 | 7 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 194 | 189 | 7 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.03e-05 | 195 | 189 | 7 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 195 | 189 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | ASK440-Endothelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.03e-05 | 195 | 189 | 7 | 1cdaab17866a1e5170e0f6bfcc69134425fdd8df | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-05 | 195 | 189 | 7 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 2.03e-05 | 195 | 189 | 7 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 196 | 189 | 7 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.09e-05 | 196 | 189 | 7 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-05 | 197 | 189 | 7 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 2.16e-05 | 197 | 189 | 7 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | distal-2-Hematologic-EREG+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.16e-05 | 197 | 189 | 7 | 6fcca7c071e35786b715adeb18be317d34315d7e | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 197 | 189 | 7 | 7eb4c1cffd0366204af7e63adc8f751685601a94 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.24e-05 | 198 | 189 | 7 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.24e-05 | 198 | 189 | 7 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.24e-05 | 198 | 189 | 7 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-05 | 199 | 189 | 7 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|normal_Lung / Location, Cell class and cell subclass | 2.31e-05 | 199 | 189 | 7 | 1ae0b47fade7b1cd74c0faabcf4f12f56f62264e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-05 | 199 | 189 | 7 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | B_cell_maturation-pre-B|B_cell_maturation / Lineage and Cell class | 2.31e-05 | 199 | 189 | 7 | 4bf6a656de04d92103cbe743cd07afd9d125c654 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.31e-05 | 199 | 189 | 7 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-05 | 199 | 189 | 7 | ffebd99d55d31cf51b4878b2690ed0b9b3799223 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.31e-05 | 199 | 189 | 7 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.31e-05 | 199 | 189 | 7 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.31e-05 | 199 | 189 | 7 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.31e-05 | 199 | 189 | 7 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.38e-05 | 200 | 189 | 7 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.38e-05 | 200 | 189 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.38e-05 | 200 | 189 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.38e-05 | 200 | 189 | 7 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.38e-05 | 200 | 189 | 7 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 2.38e-05 | 200 | 189 | 7 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| Drug | S2-o | 5.38e-07 | 9 | 187 | 4 | CID000140772 | |
| Drug | beta-carene | 5.45e-07 | 3 | 187 | 3 | CID000011129 | |
| Drug | Zr-C | 2.17e-06 | 4 | 187 | 3 | CID000449163 | |
| Drug | Bay P 8857 | 5.39e-06 | 5 | 187 | 3 | CID003086449 | |
| Drug | 4-benzyloxybutyric acid | 5.39e-06 | 5 | 187 | 3 | CID000562201 | |
| Drug | nopinone | 5.39e-06 | 5 | 187 | 3 | CID000032735 | |
| Drug | 3'dGTP | 5.60e-06 | 15 | 187 | 4 | CID000148770 | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | TPP2 KLHL2 DEAF1 KIAA0232 PRDM2 TRAK1 ALMS1 ZNF45 NINJ1 KDM6A | 6.41e-06 | 200 | 187 | 10 | 7129_DN |
| Drug | boron monoxide | 7.27e-06 | 121 | 187 | 8 | CID006327189 | |
| Drug | 8a beta-indolizidine-1 alpha, 2 alpha, 8 beta-triol | 1.26e-05 | 94 | 187 | 7 | CID000005363 | |
| Drug | 16-PC | 1.86e-05 | 7 | 187 | 3 | CID006454583 | |
| Drug | chitotetraose | 2.36e-05 | 21 | 187 | 4 | CID003080615 | |
| Drug | AC1L3OEQ | 2.96e-05 | 8 | 187 | 3 | CID000119216 | |
| Drug | MK-677 | 3.05e-05 | 73 | 187 | 6 | CID000178024 | |
| Drug | GH 5 | 3.32e-05 | 45 | 187 | 5 | CID000163897 | |
| Drug | T-E-A-T | 3.84e-05 | 76 | 187 | 6 | CID000086807 | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.13e-05 | 199 | 187 | 9 | 6492_DN | |
| Drug | gadolinium | 4.13e-05 | 199 | 187 | 9 | CID000023982 | |
| Drug | I82-2 | 4.42e-05 | 9 | 187 | 3 | CID000007899 | |
| Drug | AC1O5E2B | 4.42e-05 | 9 | 187 | 3 | CID002724224 | |
| Drug | 2,6-t | 4.42e-05 | 9 | 187 | 3 | CID000011331 | |
| Drug | chlorpropham | 5.72e-05 | 26 | 187 | 4 | CID000002728 | |
| Drug | 2-(ethylsulfonyl)ethanol | 6.26e-05 | 210 | 187 | 9 | CID000010549 | |
| Drug | Agelin | 6.27e-05 | 10 | 187 | 3 | CID000175513 | |
| Drug | AC1NRATE | 6.33e-05 | 83 | 187 | 6 | CID005288086 | |
| Drug | 7-azaindole | 7.39e-05 | 53 | 187 | 5 | CID000009222 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 7.77e-12 | 5 | 179 | 5 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 1.62e-10 | 7 | 179 | 5 | DOID:0060870 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 1.49e-08 | 14 | 179 | 5 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 1.88e-07 | 22 | 179 | 5 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Drug habituation | 5.34e-07 | 115 | 179 | 8 | C0013170 | |
| Disease | Drug abuse | 5.34e-07 | 115 | 179 | 8 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.34e-07 | 115 | 179 | 8 | C4316881 | |
| Disease | Substance-Related Disorders | 5.34e-07 | 115 | 179 | 8 | C0236969 | |
| Disease | Drug Use Disorders | 5.34e-07 | 115 | 179 | 8 | C0013222 | |
| Disease | Drug Dependence | 5.34e-07 | 115 | 179 | 8 | C1510472 | |
| Disease | Substance Dependence | 5.34e-07 | 115 | 179 | 8 | C0038580 | |
| Disease | Substance Use Disorders | 5.34e-07 | 115 | 179 | 8 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.34e-07 | 115 | 179 | 8 | C0029231 | |
| Disease | Substance abuse problem | 5.70e-07 | 116 | 179 | 8 | C0740858 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 3.78e-06 | 39 | 179 | 5 | DOID:9744 (implicated_via_orthology) | |
| Disease | cognitive function measurement | EFCAB5 KLHL2 CELF4 ERCC4 CEL TTC28 PIEZO1 PSD3 RFX6 SMC2 CSMD3 CDC14B GALNT16 FAM135B TFDP2 ZNF385D KCNG2 SEMA6D ALMS1 CELF2 LRRC53 CNTN5 | 6.17e-05 | 1434 | 179 | 22 | EFO_0008354 |
| Disease | chronic obstructive pulmonary disease | EFCAB5 FLT1 ATP8B4 ZBTB38 XKR9 PIEZO1 DOCK10 RFX6 ZNF362 ITGA1 SRFBP1 FREM3 CNTN5 DTHD1 | 8.50e-05 | 688 | 179 | 14 | EFO_0000341 |
| Disease | posterior thigh muscle volume | 9.47e-05 | 15 | 179 | 3 | EFO_0020931 | |
| Disease | Amphetamine-Related Disorders | 9.51e-05 | 75 | 179 | 5 | C0236733 | |
| Disease | Amphetamine Abuse | 9.51e-05 | 75 | 179 | 5 | C0236807 | |
| Disease | Amphetamine Addiction | 9.51e-05 | 75 | 179 | 5 | C0236804 | |
| Disease | loneliness measurement | 1.13e-04 | 124 | 179 | 6 | EFO_0007865 | |
| Disease | unipolar depression | ITGA11 CELF4 ERCC4 HLA-E DOCK10 ARFGEF2 CSMD3 FAM135B LPIN3 ZNF385D KCNG2 SEMA6D KCNT2 NALCN ASXL3 CNTN5 PLD1 NOCT CSMD1 | 1.44e-04 | 1206 | 179 | 19 | EFO_0003761 |
| Disease | cancer | 1.77e-04 | 400 | 179 | 10 | MONDO_0004992 | |
| Disease | colorectal cancer, inflammatory bowel disease | 1.98e-04 | 19 | 179 | 3 | EFO_0003767, MONDO_0005575 | |
| Disease | lymphocyte count | ZBTB38 MANBA CEL TTC28 KIAA0232 PIEZO1 PSD3 DOCK10 ITGA1 PLXND1 ELMO1 TFDP2 GH1 EOMES FOCAD PTPN12 ALMS1 CNTN5 HFM1 C1QTNF7 SETD3 | 2.30e-04 | 1464 | 179 | 21 | EFO_0004587 |
| Disease | smoking status measurement | CELF4 ERCC4 GALNT16 ELMO1 FOCAD KCNG2 SEMA6D ALMS1 CELF2 CSRNP3 CNTN5 CEP295 C1QTNF7 FKBP8 NOCT SETD3 CCDC171 DNAH8 | 2.60e-04 | 1160 | 179 | 18 | EFO_0006527 |
| Disease | health literacy measurement | 3.04e-04 | 53 | 179 | 4 | EFO_0010104 | |
| Disease | hemoglobin A1 measurement | MGAM ZBTB38 PIEZO1 PLXND1 EOMES GH2 NAA25 CSH1 CNTN5 VPS13A PLD1 | 3.56e-04 | 520 | 179 | 11 | EFO_0007629 |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 3.66e-04 | 216 | 179 | 7 | EFO_0007925, EFO_0007927 | |
| Disease | Colorectal Carcinoma | DPYSL2 LAMC1 CUBN CSMD3 ZNF385D ARNT CSRNP3 SACS VPS13A DNAH8 KDM6A PIGO PROS1 | 3.78e-04 | 702 | 179 | 13 | C0009402 |
| Disease | airway responsiveness measurement | 4.05e-04 | 24 | 179 | 3 | EFO_0006897 | |
| Disease | TEMPS-A questionnaire | 4.58e-04 | 25 | 179 | 3 | EFO_0004783 | |
| Disease | Fanconi Anemia | 4.58e-04 | 25 | 179 | 3 | C0015625 | |
| Disease | FEV/FEC ratio | EFCAB5 MGAM FLT1 ATP8B4 XKR9 KIAA0232 SKIDA1 NASP RFX6 ITGA1 SRFBP1 FCGBP CNTN5 SCUBE3 CSMD1 DTHD1 CCDC171 KPNA2 | 5.11e-04 | 1228 | 179 | 18 | EFO_0004713 |
| Disease | age at diagnosis, substance-related disorder | 5.40e-04 | 6 | 179 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 5.40e-04 | 6 | 179 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | prostate carcinoma in situ (is_marker_for) | 6.43e-04 | 28 | 179 | 3 | DOID:8634 (is_marker_for) | |
| Disease | immature platelet fraction | 6.69e-04 | 114 | 179 | 5 | EFO_0009187 | |
| Disease | telomere length | 6.83e-04 | 313 | 179 | 8 | EFO_0004505 | |
| Disease | diet measurement | DLGAP2 MGAM CELF4 ZBTB38 SKIDA1 ARFGEF2 SMC2 GH2 SEMA6D CELF1 CSH1 CELF2 NALCN CNTN5 CSMD1 CCDC171 | 6.91e-04 | 1049 | 179 | 16 | EFO_0008111 |
| Disease | Miller Dieker syndrome | 7.14e-04 | 29 | 179 | 3 | C0265219 | |
| Disease | creatinine measurement, glomerular filtration rate | 7.52e-04 | 117 | 179 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | Headache, fasting blood glucose measurement | 7.53e-04 | 7 | 179 | 2 | EFO_0004465, HP_0002315 | |
| Disease | susceptibility to mononucleosis measurement | 8.33e-04 | 69 | 179 | 4 | EFO_0008403 | |
| Disease | Malignant neoplasm of breast | RAD51 FLT1 ARFGEF2 CUBN TTC3 GALNT16 ZNF404 EOMES FOXP4 NAA25 KCNT2 PER3 BRCA2 HEY1 HSPA14 GOLGB1 | 8.86e-04 | 1074 | 179 | 16 | C0006142 |
| Disease | PR interval | EFCAB5 SPTBN1 LAMC1 ELMO1 TRAK1 GH1 EOMES CSHL1 HFM1 C1QTNF7 | 9.34e-04 | 495 | 179 | 10 | EFO_0004462 |
| Disease | uridine measurement | 9.57e-04 | 32 | 179 | 3 | EFO_0010546 | |
| Disease | Thrombophilia due to thrombin defect | 1.00e-03 | 8 | 179 | 2 | cv:C3160733 | |
| Disease | Fanconi anemia (implicated_via_orthology) | 1.00e-03 | 8 | 179 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | age at menarche | DLGAP2 TTC28 MYO6 INO80 PRDM2 SEMA6D ALMS1 CELF1 LRRC53 CNTN5 CSMD1 | 1.06e-03 | 594 | 179 | 11 | EFO_0004703 |
| Disease | wellbeing measurement | DLGAP2 CELF4 ERCC4 ARFGEF2 ODAD2 KCNG2 SEMA6D CELF2 ASXL3 CNTN5 RASEF SERPINC1 | 1.12e-03 | 692 | 179 | 12 | EFO_0007869 |
| Disease | behavioural disinhibition measurement | 1.14e-03 | 75 | 179 | 4 | EFO_0006946 | |
| Disease | depressive symptom measurement | 1.23e-03 | 426 | 179 | 9 | EFO_0007006 | |
| Disease | waist-hip ratio, metabolic syndrome | 1.28e-03 | 9 | 179 | 2 | EFO_0000195, EFO_0004343 | |
| Disease | PITUITARY DWARFISM I | 1.28e-03 | 9 | 179 | 2 | C0342573 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.34e-03 | 133 | 179 | 5 | EFO_0010092 | |
| Disease | urate measurement, bone density | DLGAP2 DPYSL3 ERCC4 TTC28 PSD3 GBP3 PPL FSIP2 GBP5 DNAH8 ATP2B2 | 1.47e-03 | 619 | 179 | 11 | EFO_0003923, EFO_0004531 |
| Disease | response to risperidone | 1.58e-03 | 38 | 179 | 3 | GO_0097336 | |
| Disease | Hodgkins lymphoma | 1.58e-03 | 82 | 179 | 4 | EFO_0000183 | |
| Disease | postburn hypertrophic scarring severity measurement | 1.59e-03 | 10 | 179 | 2 | EFO_0007747 | |
| Disease | Russell-Silver syndrome | 1.59e-03 | 10 | 179 | 2 | C0175693 | |
| Disease | Malignant neoplasm of urinary bladder | 1.73e-03 | 141 | 179 | 5 | C0005684 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.07e-03 | 147 | 179 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | platelet crit | DEAF1 TTC28 PIEZO1 HLA-E DOCK10 ACTN1 CUBN PIAS1 EOMES LPIN3 NAA25 MEIOC CNTN5 HFM1 | 2.09e-03 | 952 | 179 | 14 | EFO_0007985 |
| Disease | age at assessment, pelvic organ prolapse | 2.27e-03 | 43 | 179 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression | 2.73e-03 | 13 | 179 | 2 | EFO_0003761, EFO_0003888 | |
| Disease | N-acetylglutamine measurement | 2.73e-03 | 13 | 179 | 2 | EFO_0800017 | |
| Disease | aseptic loosening | 2.73e-03 | 13 | 179 | 2 | EFO_0010725 | |
| Disease | dimethylglycine measurement | 2.75e-03 | 46 | 179 | 3 | EFO_0010476 | |
| Disease | homocysteine measurement | 2.75e-03 | 46 | 179 | 3 | EFO_0004578 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 2.93e-03 | 47 | 179 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | psychosis | 3.17e-03 | 14 | 179 | 2 | EFO_0005407 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 3.17e-03 | 14 | 179 | 2 | C0677776 | |
| Disease | opioid dependence | 3.34e-03 | 237 | 179 | 6 | EFO_0005611 | |
| Disease | neurotic disorder | 3.38e-03 | 101 | 179 | 4 | EFO_0004257 | |
| Disease | Bell's palsy | 3.51e-03 | 102 | 179 | 4 | EFO_0007167 | |
| Disease | infant head circumference | 3.65e-03 | 15 | 179 | 2 | EFO_0004577 | |
| Disease | risky sexual behaviour measurement | 3.78e-03 | 169 | 179 | 5 | EFO_0007877 | |
| Disease | mean platelet volume | LDLRAP1 ATP8B4 ZBTB38 TTC28 KIAA0232 SPTBN1 PSD3 DOCK10 ACTN1 PLXND1 ELMO1 CELF2 MEIOC DSE | 3.87e-03 | 1020 | 179 | 14 | EFO_0004584 |
| Disease | melanoma | 4.17e-03 | 248 | 179 | 6 | C0025202 | |
| Disease | Respiratory Distress Syndrome, Adult | 4.57e-03 | 55 | 179 | 3 | C0035222 | |
| Disease | erythrocyte cadmium measurement | 4.69e-03 | 17 | 179 | 2 | EFO_0007807 | |
| Disease | feeling emotionally hurt measurement | 4.81e-03 | 56 | 179 | 3 | EFO_0009599 | |
| Disease | ovarian cancer (is_implicated_in) | 4.81e-03 | 56 | 179 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | myocardial infarction | 5.69e-03 | 350 | 179 | 7 | EFO_0000612 | |
| Disease | lymphocyte measurement | 5.70e-03 | 117 | 179 | 4 | EFO_0803546 | |
| Disease | hippuric acid measurement | 5.85e-03 | 19 | 179 | 2 | EFO_0010496 | |
| Disease | Hypermetropia, Myopia | 6.04e-03 | 189 | 179 | 5 | HP_0000540, HP_0000545 | |
| Disease | attention deficit hyperactivity disorder | 6.04e-03 | 354 | 179 | 7 | EFO_0003888 | |
| Disease | immature platelet measurement | 6.05e-03 | 119 | 179 | 4 | EFO_0803541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IRFNSQSQAEAHYKG | 81 | Q96PM9 | |
| QLRFNSDSQAAAHYK | 86 | Q9H6B1 | |
| ERYGQIQQAKSHFAA | 191 | Q15699 | |
| IQQAKSHFAATYDIS | 196 | Q15699 | |
| RFSEIYHNINADQSK | 556 | P27540 | |
| AKGFRDNYDSSHQIV | 451 | O95936 | |
| HQENSKNSYTESRSF | 106 | P56851 | |
| YTRKAALEAQNALHN | 91 | O95319 | |
| RHASQDELAASAYQA | 446 | O75366 | |
| LQHADSSNFYITEKN | 51 | Q92556 | |
| FSYENSHSQAINVDR | 31 | Q99218 | |
| YHAFSGAQKAETAAN | 246 | P12814 | |
| SDHSQNRQGFKLAYQ | 2066 | Q96PZ7 | |
| TTDNSRSNNGFKIHY | 986 | Q7Z407 | |
| VNHDFFIYSQSNISK | 216 | Q9UKJ8 | |
| KSASNVHYFSIDNEL | 66 | O60729 | |
| FYTRKAALEAQNALH | 66 | Q92879 | |
| SAYEREKHNAQESFA | 341 | Q6TFL3 | |
| SAKNHQSAAEYNIFE | 421 | Q14195 | |
| SHSFSKAFNSNYEQR | 1621 | Q9Y6D5 | |
| YSNREKASIFHQQEL | 1896 | Q8TCU4 | |
| KQTYSKFDTNSHNHD | 171 | Q14406 | |
| TENVKYRQVDHFASN | 156 | Q8N302 | |
| FHTLQYQRTSAAAEQ | 206 | Q9P1A6 | |
| YHADVNAADNEKRSA | 1001 | Q9ULJ7 | |
| ATDDYFRHKSDNQVN | 96 | Q8TF62 | |
| ATTFYQHLADSKNDN | 91 | P01008 | |
| NLAKFHVDRNQLSSY | 196 | O15335 | |
| LAQHRANAKSAKTYA | 421 | P19835 | |
| KSASNVHYFSIDNEL | 36 | A4D256 | |
| DNQYAVLENQKSSHS | 241 | Q9UKY7 | |
| NTFNVQSKEEHAYRL | 56 | Q5W186 | |
| YHSQSRAAVTIQKAF | 2811 | Q8IZT6 | |
| EANIRSYAKSHDKAN | 131 | Q6P1M9 | |
| NSDFYSKNQRNESSH | 6 | Q01814 | |
| KYNQRNSTDENFHAS | 661 | Q9C0F0 | |
| ATDDYFRHKSDNQVN | 116 | P98198 | |
| NLYHSSDAFKQDESV | 81 | O94779 | |
| YRQHAFNQLESDKLS | 86 | Q8N428 | |
| RYVSNHAFNQSAELK | 466 | Q6UXK2 | |
| ENSYSKFNRSLHINN | 361 | Q8IZ41 | |
| RYVTNKFDSQAFHTI | 26 | Q9NP90 | |
| LDNVAYARAFNTDHQ | 186 | Q06609 | |
| DNHDSKTKAADQYLS | 91 | Q8HWS3 | |
| NITQEDYDSNHFKAQ | 436 | Q9ULG1 | |
| AAFDKSHDQAVRTYQ | 576 | P09960 | |
| DALQYHNNTAFSTKD | 261 | O43827 | |
| DKVFAYIAQSQHNQS | 126 | Q5SW96 | |
| KRNLGANHYSSDSQL | 361 | A5PLL1 | |
| ATYNSDRDNSFLQVH | 286 | Q9Y698 | |
| YALRSFNHEQTKAFE | 516 | Q8TAB3 | |
| YNDSAHYALTRFNKQ | 671 | Q7L576 | |
| DISLEKFNQHSVSYQ | 451 | Q9BQK8 | |
| QKSNDASEAEHQRAY | 166 | P13747 | |
| SAKTHNSSLEYNIFE | 421 | Q16555 | |
| RNQTQLLDAHKTDSY | 926 | A6NM62 | |
| DKHLSSQNRYFSEAD | 421 | P12268 | |
| EYQTSNRFHFKLTDQ | 176 | O43451 | |
| NRSHTTIAKYAQYQA | 1026 | O15550 | |
| QLRKNHSSAQFIDSY | 301 | Q9BY66 | |
| TYQRAILQNHTDFKD | 171 | Q86X55 | |
| KQTYSKFDTNSHNHD | 166 | P0DML3 | |
| SHAKNASFYANSSTL | 421 | Q8WYN3 | |
| VKNQADFHYSVASQF | 351 | Q86SJ6 | |
| AFREHQQYKTAEFLS | 181 | Q96J88 | |
| VDYHFESNVRNKSFS | 3621 | Q5CZC0 | |
| AAFQSQYKSHFVAAS | 701 | Q86XP3 | |
| AAVLSAHTQKEEQNY | 676 | P56645 | |
| HLAEESRKYQNEFNT | 1856 | Q9Y4D7 | |
| HTFSRSYSELKEQQQ | 406 | Q9UJ96 | |
| SNNNLHKTYLAAGTF | 451 | Q92628 | |
| RAQSLQSAKAAYEHF | 721 | O60437 | |
| NDLQVTSLNHKYFRT | 3486 | Q96JB1 | |
| QQLDVFIATSKHAYA | 681 | Q9UL01 | |
| ENSAAVQKAIAHYDQ | 321 | Q9H0R5 | |
| ENSAAVQKAIAHYDQ | 321 | Q96PP8 | |
| SSFEYGQVNHALAAA | 281 | Q9BSJ2 | |
| HFRNDTNTQSFYREK | 71 | Q8TCJ0 | |
| SSELAQNHEFYKNAD | 451 | Q8IVH2 | |
| SQELHKDTSRLYNFN | 71 | P41439 | |
| LKDSHSYQNARFGSS | 531 | Q9UKX5 | |
| QDQQRKSNVSRSFYH | 566 | Q6UVM3 | |
| ENVTHEFNLNKYSST | 216 | P56199 | |
| ALDQYKLRQASIHSN | 211 | Q9NQS5 | |
| RQETKEAQLYAAQAH | 531 | P49321 | |
| QRHYTSRADSDANSK | 446 | Q9NZB8 | |
| AAHLVNALNFSVNYS | 121 | Q9NPH5 | |
| INVNHYASKKSAAES | 36 | Q92982 | |
| LFKISDNIHGSAYSN | 166 | A2PYH4 | |
| LQNHENESVYKASLS | 476 | P52292 | |
| VASSNQVFIKFHADY | 3596 | O60494 | |
| NQSRNKHDYNGSFLA | 1091 | A4FU69 | |
| NNLAASQLKLDHYRA | 276 | Q14318 | |
| SRDATFHYGEQAAKN | 871 | O75054 | |
| QFQAHKALLATQSDY | 41 | Q96M94 | |
| TDSSENNLHADFAKY | 326 | Q96BY6 | |
| AAAAAFLQQRNSYNH | 101 | Q7Z5Q1 | |
| TANVKSYFSNHDESL | 226 | P51587 | |
| TDFQSQKSLLYDHEN | 751 | P51587 | |
| DNKYTAASRNSHNLE | 1321 | P51587 | |
| ASHLNVSQYNTEARK | 2281 | Q9H799 | |
| QAKHASTYREAATNQ | 476 | O75398 | |
| STYREAATNQAKIHA | 481 | O75398 | |
| AFVVASQATKLTYNH | 266 | Q9Y6R7 | |
| QNTTYFLAQHLNKDS | 826 | Q5JV73 | |
| AHLKAQQDTFYSVQS | 351 | Q6ZMT9 | |
| INHKYRNSSNTADIT | 346 | Q9NV96 | |
| SSLDTNNNSHYQKKR | 271 | Q5U623 | |
| SAVLYAAQQSKAHTR | 146 | O00462 | |
| VQKAVDDLNLHSYSN | 881 | Q14204 | |
| SHLNNYASQREAASG | 156 | Q9Y5J3 | |
| HGAAFLTDYNNQADT | 101 | P11047 | |
| AFNAQHESRSSRDKY | 571 | Q49AJ0 | |
| DIYQRQNSSDVHKSL | 2016 | Q9C0D2 | |
| KQTYSKFDTNSHNHD | 166 | P0DML2 | |
| VHARAAQYSKAAQDV | 16 | Q8IX30 | |
| NAYVDSEKVSFHLNF | 2351 | Q9NZJ4 | |
| YRIKTFDANTGNHDV | 216 | Q9BXJ2 | |
| EEVYKHFASSSLNLN | 331 | Q9UK39 | |
| HKSKQNLSDRSRQAY | 246 | Q5SRE7 | |
| YQSTSFHNTALDKAL | 1656 | Q5VW36 | |
| NREFTYIGSLNKHAA | 1461 | Q13029 | |
| AQYLASEFQRSFKHD | 236 | Q0VDF9 | |
| RVKGSNYHLSDNDAS | 631 | Q96QE2 | |
| THFQKNFLRYIDQDS | 721 | P0C091 | |
| HSEYFKSVNLLSNSA | 451 | A2RUB1 | |
| DRQANHKDQLSYYET | 351 | Q96M34 | |
| KDHRFGSYAAIQENA | 336 | Q13393 | |
| YLKSNDTNVHRATAQ | 971 | Q5T2S8 | |
| VSSEQHSADLNRNYS | 396 | Q05209 | |
| SVQAQANFLYHLASA | 476 | Q1XH10 | |
| HKSVSSNDAYNFNLE | 326 | Q5FBB7 | |
| SFADDFVRSSKQHYN | 141 | P50454 | |
| YHALSQKEANDSDVQ | 6 | O95707 | |
| QAIHDVFSQYKNTAR | 201 | Q86TU7 | |
| AHSNFTYDASNQVLL | 901 | P14410 | |
| GDNQHYNTSLLAAAA | 551 | O75925 | |
| AQFHIDYNNVSSAEG | 491 | P07225 | |
| EISSDQFNEHYSARN | 496 | Q8N1H7 | |
| EFTNSNNHLAADSAY | 161 | Q14188 | |
| NNHLAADSAYDQKNI | 166 | Q14188 | |
| SQSHAYQQFLRDTKQ | 1166 | Q01082 | |
| TANFYQKADHTLSSL | 216 | Q5VW32 | |
| NEFRFSQVSKNDLYH | 96 | P78348 | |
| FVKYSSHAEAQAAIN | 196 | Q9BZC1 | |
| KQAATQSELHYANLE | 221 | Q9UGN4 | |
| SESDHFSYVQLRNAA | 921 | Q96JQ2 | |
| SDFHNSKQFSNDVYT | 21 | Q8IXP5 | |
| KRNESSSSVQNYFHL | 196 | Q9UPV9 | |
| SSSVQNYFHLDSLQK | 201 | Q9UPV9 | |
| YRSNQVEKFTNHRSS | 146 | Q8N9Z0 | |
| NQSYSKFDTKSHNDD | 166 | P01242 | |
| HFNSTYNARVKAFNS | 576 | Q6ZTA4 | |
| FREKDSSSNLSYQSH | 131 | Q96T68 | |
| KAQAYLKVNANSHAR | 141 | Q8TAG5 | |
| KVEYNTSAHQSSFRI | 2631 | Q96RL7 | |
| AYAKARTANSHLSNL | 761 | Q9Y5T5 | |
| GKAFNSSSYLQLHER | 396 | Q9ULM2 | |
| SKNASEDNHSENTLY | 136 | Q8NEF9 | |
| QLKTQAVDFINYHAS | 316 | O43791 | |
| NVNDSSNEKRHSYLL | 126 | P47872 | |
| NSNKITVRFHSDQSY | 421 | Q9Y5Y6 | |
| AAKVNESSHYDLAFT | 636 | P29144 | |
| YSDASVQRKGFQAVH | 871 | Q9Y6L7 | |
| QFSKSSRAAHQDFAN | 471 | P53804 | |
| KQTYSKFDTNSHNDD | 166 | P01241 | |
| DKVRIAYHSANANSY | 426 | Q86WI1 | |
| QRISLHKASESQSFY | 811 | Q86WI1 | |
| GKYFSRSANLIQHQS | 171 | O75290 | |
| TLTLAQAHFNNGEYA | 11 | Q5I0X7 | |
| SNKDAEALAAAQQHF | 366 | O95347 | |
| LSSEKRNYEVNAYHQ | 56 | Q494X3 | |
| DGLHFNSTYNARVKA | 501 | Q9C026 | |
| KQSVSIRDSAHQYFI | 146 | Q86XU0 | |
| ALFQSSNLGDHQKSY | 551 | Q86XU0 | |
| TSQNQFSEHDKTLYR | 1311 | Q07157 | |
| QDHDRSKNAYLQRST | 2021 | Q96AY4 | |
| SKSFANASYLAQHLR | 261 | Q5T0B9 | |
| ESSHRYEVSGQNFKQ | 96 | Q96JF6 | |
| YSAATQDLQAKELHQ | 381 | Q8TEQ8 | |
| EHSSSNKRNVNNRSY | 706 | Q6R2W3 | |
| FASFNAYENHLKSRR | 76 | Q969S3 | |
| NNQTDKAQVHAVSFY | 181 | Q5PR19 | |
| ALYNAANLKSIDFHR | 1326 | Q92508 | |
| AANAKQLYDFIHTSF | 891 | Q92889 | |
| AHSNVLAASSLYFKN | 46 | Q8NAP3 | |
| NLNQETRTFHSLKDY | 156 | A6NGJ6 | |
| RIDQSNSHANIFYSV | 281 | P17948 | |
| DYNTSFSNSNAHKAE | 836 | Q8NFY4 | |
| YHFSRAEQSKAEEAQ | 846 | Q8IWV8 | |
| NLNQETSTFHSLKDY | 156 | A6NI03 | |
| NASAHSQSVAKAKYE | 16 | Q9NYI0 | |
| QRVHSRAKSYTNDAS | 211 | Q02386 | |
| HAAFKYDSNTSNFVE | 101 | Q5GH70 | |
| FYFHVADNNEKSLQA | 256 | Q8WU03 | |
| SKDFSSHDEINNYLQ | 1826 | Q14789 | |
| TDLLNKANTYAEQHF | 171 | O95198 | |
| KYGENINRHANFSSA | 1361 | Q8IZF0 | |
| NQARFGHFTLAYSAK | 176 | Q13508 | |
| ANNARDALAKTVYSH | 416 | Q9UM54 | |
| ALRFFHSNQKDTSEY | 566 | Q14CX7 |